Auf Mastodon teilen

Antrag nach EU-Verordnungen 1049/2001 sowie 1367/2006 Guten Tag, auf Basis der Verordnungen 1049/2001 sowie 1367/2006 bitte ich Sie um Übersendung von Dokumenten, die folgende Informationen enthalten:

Das Versäumnis der Europäischen Arzneimittel-Agentur (EMA), einen Antrag auf Zugang der Öffentlichkeit zu Dokumenten zu registrieren und zu beantworten Sehr [geschwärzt], Sie haben sich mit einer Beschwerde gegen die Europäische Arzneimittel-Agentur (EMA) an die Europäische Bürgerbeauftragte gewandt. Ihre Beschwerde betrifft das Versäumnis der EMA, Ihren Antrag auf Zugang der Öffentlichkeit zu Dokumenten, den Sie über die Plattform FragDenStaat.de (#286296) eingereicht haben, zu registrieren und zu beantworten. Wir haben die EMA ersucht, Ihren Antrag sobald wie möglich, spätestens aber bis zum 6. Oktober 2023 zu registrieren und innerhalb der vorgeschriebenen Frist von 15 Werktagen zu beantworten. Bei Fragen wenden Sie sich bitte unter folgender Telefonnummer an die zuständige Untersuchungsbeauftragte, [geschwärzt], +[geschwärzt] Mit freundlichen Grüßen, [[geschwärzt]] [geschwärzt] [geschwärzt] [geschwärzt] [geschwärzt] [geschwärzt] +[geschwärzt]<+[geschwärzt]> [geschwärzt]<[geschwärzt]>

Dear Mr << Antragsteller:in >>, Thank you for contacting us on 16 August 2023. We hereby acknowledge receipt of your application for access to documents, which was registered under reference number ASK-151664. Please note that your request for access to documents reached the ATD Service only on 19 September 2023. This is due to the fact that your request was sent via email to a different EMA department, and was not submitted via our webform (https://www.ema.europa.eu/en/about-us/contact/send-question-european-medicines-agency<https://urldefense.com/v3/__https:/www.ema.europa.eu/en/about-us/contact/send-question-european-medicines-agency__;!!MBaoSxY!7wnk6KOpccuq_CVjWbMp369yjBtm3heob17LyuPOOwdHaRl8NQwu_aLgN2lPuqCv_NRL8GHJsaEtYpbfZLkZfx9zTZG4vfTTB_TT3Q$>), which would have ensured to be seen at the time of submission. We will deal with your request as soon as possible and in accordance with the principles and limits established in Regulation (EC) 1049/2001 regarding public access to European Parliament, Council and Commission documents (the Regulation), as applicable to the EMA pursuant to Article 73 of Regulation (EC) 726/2004. In accordance with the Regulation, you will receive a reply via a secure Eudralink within 15 working days. The Agency may extend this period by a further 15 working days in exceptional circumstances in accordance with the Regulation. Please note that EMA cannot currently process all access-to-documents requests at the same time. This is because their number increased while EMA was operating under a business continuity plan during the COVID-19 pandemic. EMA is making every effort to process all requests as soon as possible. However, you should be aware that due to these circumstances, we may have to extend the deadline as outlined above. Should such an extension be applied by the Agency, you will be informed at the time. Kind regards,

+++++++++++++++++++++++++++++++++++++++++++++ You have been sent a package by "European Medicines Agency" <<Name und E-Mail-Adresse>> To retrieve your package use the hyperlink below (click or paste it into browser address bar): https://eudralink.ema.europa.eu/dl.php?d=a140052378f339f6fcd569b999358448 The package will expire on Mon, 08 Jan 2024 15:28:41 +0100 If you forward this email notification, only registered Eudralink users within your organisation (with the same domain) will be able to access it*. You should create a new package to send to third parties. +++++++++++++++++++++++++++++++++++++++++++++ *Other restrictions apply. See https://eudralink.ema.europa.eu/EudraLink-User-Guide.pdf (search forwarding)

Dear Mr << Antragsteller:in >>, The decision regarding the above request has just been released to you via a secure Eudralink. Please note that you will need to enter the following password to access this Eudralink package: ASK-151664-2023. Kind regards,